Researchers track Real-Life results of popular breast cancer drug
NCT ID NCT06495164
Summary
This study looks at how the breast cancer drug palbociclib is actually used in everyday medical practice and what results patients experience. Researchers will analyze anonymous medical records of adults with advanced hormone-positive breast cancer who started treatment between 2015 and 2022. The goal is to understand treatment patterns, how long patients stay on different medications, and whether these treatments affect when patients might need chemotherapy later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer New York
New York, New York, 10001, United States
Conditions
Explore the condition pages connected to this study.